To cite this paper use one of the standards below:
INTRODUCTION AND OBJECTIVES: Cervical cancer is the fourth most common cancer among women worldwide. In spite of great advances in available treatments, a great number of patients still face cancer recurrence, especially in the advanced stages of the disease. The infiltration of neutrophils in tumors has been associated with worse prognosis, and evidence shows that neutrophil extracellular traps (NETs) can stimulate tumor growth, aggressiveness and metastasis. Data published by our group show that NETs promote a pro-metastatic phenotype in breast cancer cells; however, little is known about the influence of NETs on cervical cancer progression and chemoresistance. In the present study, we investigated the pro-tumorigenic effects of isolated NETs on the cervical cancer cell line CASKI, especially in regard to the acquisition of resistance to apoptosis. MATERIALS AND METHODS: In this study, we employed the cervical cancer cell line, CASKI, which is derived from a metastatic site in the small intestine and displays an aggressive phenotype. Neutrophils isolated from the blood of healthy donors were stimulated with PMA to produce NETs which were further isolated using an established protocol. To evaluate cytotoxicity through MTT assay, the cervical cancer cells were treated with isolated NETs for 24 h. Following this, samples were generated for real-time PCR, and the expression of Bcl-2, Bcl-xL, Bax and BIM was analyzed. Finally, treatment with cisplatin was performed for 48 h. RESULTS AND CONCLUSION: In vitro analysis showed that NETs were not cytotoxic to the cell line CASKI. NETs treatment significantly downregulated the mRNA expression of BIM, a proapoptotic protein, but also downregulated the expression of the antiapoptotic protein Bcl-xL. Western blot experiments to fully corroborate these findings are currently underway. Moreover, MTT assay results showed that NETs are able to protect CASKI cells against cisplatin treatment. In summary, we conclude that NETs modulate the expression of apoptosis-related proteins and induce resistance to cisplatin treatment in CASKI cells. Considering the data obtained so far, we intend to perform functional assays like the colony forming assay and apoptosis analysis by flow cytometry to further investigate the ability of NETs to protect cervical cancer cells from the cytotoxic effects of the chemotherapeutic drugs cisplatin and paclitaxel. Additionally, we plan to evaluate the effects of NETs treatment on a primary cervical cancer cell line, C33A.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper